Source comparison
IGF-1 LR3 vs MK-677: Research Comparison
The following table summarizes the key pharmacological, mechanistic, and practical differences between IGF-1 LR3 and MK-677 for research applications. Mechanism Direct IGF-1 receptor agonist Ghrelin receptor agonist (GH secretagogue) IGF-1 LR3 bypasses pituita
This comparison does not assign a generated winner or score.
- The following table summarizes the key pharmacological, mechanistic, and practical differences between IGF-1 LR3 and MK-677 for research applications.
- Mechanism
- Direct IGF-1 receptor agonist
- Ghrelin receptor agonist (GH secretagogue)
- IGF-1 LR3 bypasses pituitary; MK-677 works through endogenous GH release
- Half-Life
- 20–30 hours (plasma)
- 4–6 hours (drug); 24+ hours (GH elevation)
- IGF-1 LR3 requires less frequent dosing but shorter pharmacodynamic window
- Route of Administration
- Subcutaneous or intramuscular injection
- Oral (capsule or liquid)
- MK-677 simplifies chronic dosing protocols and reduces injection-related stress
- Receptor Selectivity
- IGF-1R (high affinity); IR (cross-reactivity at high dose)
- GHSR-1a (ghrelin receptor)
- IGF-1 LR3 may produce hypoglycemia; MK-677 increases appetite and energy expenditure
- Tissue Distribution
- Broad (reduced IGFBP binding)
- Systemic via hepatic and peripheral IGF-1 synthesis
- IGF-1 LR3 allows targeted tissue studies; MK-677 models systemic GH-IGF-1 axis
- Typical Research Dose
- 0.1–1.0 mg/kg (animal models); 10–100 ng/mL (cell culture)
- 2–10 mg/kg (rodents); 10–25 mg (human trials)
- Dose scaling and route differ significantly between compounds
- Feedback Loop Involvement
- Minimal (exogenous IGF-1 analog)
- Full (endogenous GH subject to somatostatin regulation)
- MK-677 may show attenuated response in chronic studies; IGF-1 LR3 maintains consistent effect
- Primary Research Applications
- Muscle hypertrophy, wound healing, tendon/ligament repair, direct IGF-1R signaling
- Metabolic studies, bone density, lean mass, appetite regulation, GH deficiency models
- Select based on whether the study requires direct receptor activation or systemic hormonal modeling